Family Medicine · Pasadena, CA
NPI
1982373015
Since 2021
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2319 E Washington Blvd # 2
Pasadena, CA, 91104
Phone (626) 797-8800
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$322K
2,282 prescriptions
Company payments, 2025
$3,390
From 31 companies
Medicare prescription drug claims, 2024
In 2024, the drug Johnathan Che prescribed most often to Medicare patients was Azithromycin, with 187 prescriptions and refills. In total Johnathan Che wrote 2,282 Medicare prescriptions that cost $322K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Azithromycin Generic | 187 | 187 | 115 | $1,875 |
| Alprazolam Generic | 108 | 126 | 24 | $1,132 |
| Eszopiclone Generic | 91 | 121 | 19 | $7,083 |
| Clonazepam Generic | 83 | 85 | 14 | $811 |
| Zolpidem Tartrate Generic | 78 | 122 | 27 | $558 |
| Testosterone Cypionate Generic | 76 | 136 | 23 | $4,099 |
| Testosterone Generic | 72 | 88 | 16 | $11K |
| Lorazepam Generic | 65 | 80 | 25 | $690 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 57 | 57 | 16 | $1,457 |
| Prednisone Generic | 56 | 68 | 44 | $201 |
| Xyosted Testosterone Enanthate | 54 | 92 | 13 | $58K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 46 | 46 | Under 11 | $1,180 |
| Ciprofloxacin Hcl Generic | 42 | 42 | 29 | $306 |
| Belsomra Suvorexant | 39 | 53 | Under 11 | $22K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 38 | 38 | 32 | $365 |
Brand drugs: - claims; generic drugs: 1,949 claims; opioid claims: 173.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Johnathan Che $3,390 ($3,390 in general payments such as food, travel and fees) from 31 companies. The largest payer was Abbvie Inc. with $389.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $389 |
| Bausch Health US, LLC BHC | 19 | $289 |
| Amgen Inc. AMGN | 21 | $273 |
| Axsome Therapeutics, Inc. AXSM | 10 | $256 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $241 |
| Antares Pharma, Inc. | 8 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 10 | $174 |
| Gilead Sciences, Inc. GILD | 9 | $159 |
| Lundbeck LLC | 7 | $154 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.